Medipal Holdings (TSE:7459) Cyclically Adjusted Revenue per Share: 円16,638.20 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7459 Medipal Holdings Corp TSE:7459
82 GF Score
Price 円3,002.00
GF Value 円2,736.16
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Medipal Holdings Cyclically Adjusted Revenue per Share?

Medipal Holdings TSE:7459 -2.02% 82 Cyclically Adjusted Revenue per Share is 円16,638.20 as of Mar. 2026. GuruFocus rates TSE:7459 with a GF Score™ of 82/100 and a GF Value™ of 円2,736.16 (Fairly Valued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medipal Holdings's adjusted revenue per share for the three months ended in Mar. 2026 was 円4,400.705. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円16,638.20 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Medipal Holdings's average Cyclically Adjusted Revenue Growth Rate was 3.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 4.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Medipal Holdings was 5.00% per year. The lowest was 2.20% per year. And the median was 3.55% per year.

As of today (2026-07-31), Medipal Holdings's current stock price is 円3002.00. Medipal Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was 円16,638.20. Medipal Holdings's Cyclically Adjusted PS Ratio of today is 0.18.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medipal Holdings was 0.21. The lowest was 0.11. And the median was 0.16.


Medipal Holdings  (TSE:7459) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medipal Holdings's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3002.00/16638.20
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medipal Holdings was 0.21. The lowest was 0.11. And the median was 0.16.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medipal Holdings Cyclically Adjusted Revenue per Share Related Terms


Medipal Holdings Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Medipal Holdings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medipal Holdings Cyclically Adjusted Revenue per Share Chart

Medipal Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13,888.65 14,576.51 15,194.64 16,087.64 16,638.20

Medipal Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16,087.64 16,257.58 16,388.38 16,616.49 16,638.20

TSE:7459 vs MCK, COR, CAH: Cyclically Adjusted Revenue per Share Comparison

For the Medical Distribution subindustry, Medipal Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medipal Holdings Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medipal Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medipal Holdings's Cyclically Adjusted PS Ratio falls into.


TSE:7459
82GF Score
Medipal Holdings Corp TSE:7459
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medipal Holdings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medipal Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=4400.705/112.7000*112.7000
=4,400.705

Current CPI (Mar. 2026) = 112.7000.

Medipal Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 3,407.757 98.100 3,914.926
201609 3,351.331 98.000 3,854.031
201612 3,529.339 98.400 4,042.241
201703 3,242.993 98.100 3,725.640
201706 3,446.400 98.500 3,943.241
201709 3,445.479 98.800 3,930.217
201712 3,691.039 99.400 4,184.910
201803 3,169.138 99.200 3,600.422
201806 3,370.361 99.200 3,829.029
201809 3,300.901 99.900 3,723.839
201812 3,558.545 99.700 4,022.548
201903 3,212.598 99.700 3,631.492
201906 3,431.711 99.800 3,875.289
201909 3,587.948 100.100 4,039.578
201912 3,708.633 100.500 4,158.835
202003 3,441.200 100.300 3,866.633
202006 3,546.808 99.900 4,001.254
202009 3,543.338 99.900 3,997.339
202012 3,791.695 99.300 4,303.364
202103 3,451.702 99.900 3,893.962
202106 3,687.277 99.500 4,176.443
202109 3,656.542 100.100 4,116.806
202112 3,862.950 100.100 4,349.195
202203 3,491.879 101.100 3,892.530
202206 3,744.592 101.800 4,145.536
202209 3,801.085 103.100 4,155.017
202212 4,200.865 104.100 4,547.911
202303 3,772.244 104.400 4,072.145
202306 4,146.828 105.200 4,442.467
202309 4,199.900 106.200 4,456.956
202312 4,439.329 106.800 4,684.573
202403 4,017.621 107.200 4,223.749
202406 4,336.627 108.200 4,516.986
202409 4,379.123 108.900 4,531.930
202412 4,708.346 110.700 4,793.411
202503 4,144.812 111.100 4,204.503
202506 4,552.263 111.700 4,593.017
202509 4,604.584 112.000 4,633.363
202512 4,919.019 113.000 4,905.960
202603 4,400.705 112.700 4,400.705

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of 円16,638.20 mean?
Medipal Holdings (TSE:7459) has a Cyclically Adjusted Revenue per Share of 円16,638.20 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medipal Holdings and its competitors.
Is Medipal Holdings' Cyclically Adjusted Revenue per Share too high?
Medipal Holdings' current Cyclically Adjusted Revenue per Share is 円16,638.20. Overall, Medipal Holdings has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Cyclically Adjusted Revenue per Share compare to MCK and COR?
Medipal Holdings' Cyclically Adjusted Revenue per Share of 円16,638.20 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Distribution company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medipal Holdings and its competitors. Medipal Holdings's current Cyclically Adjusted Revenue per Share is 円16,638.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (TSE:7459) is currently considered Fairly Valued. The stock's GF Value™ is 円2,736.16, compared to a current price of 円3,002.00 — trading 9.7% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is 円16,638.20. Medipal Holdings' overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Medipal Holdings (TSE:7459), the current Cyclically Adjusted Revenue per Share is 円16,638.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medipal Holdings (TSE:7459) Overvalued in 2026?

Based on GuruFocus' analysis, Medipal Holdings stock appears to be overvalued. The current stock price of 円3,002.00 is trading 9.7% above its estimated GF Value™ of 円2,736.16. GuruFocus considers Medipal Holdings to be Fairly Valued.

Key valuation signals for TSE:7459:

  • Cyclically Adjusted Revenue per Share: 円16,638.20
  • GF Value™: 円2,736.16 vs. price of 円3,002.00 (9.7% above fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the TSE:7459 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medipal Holdings Business Description

Other Exchanges MEPDF:USAMAHLY:USA
Address 3-1-1 Kyobashi, Chuo-ku, Tokyo, JPN, 104-8461
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
82GF Score

Get the complete analysis for TSE:7459

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,002.00
Price
円2,736.16
GF Value